Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
Noise can play an important role in the initiation and progression of ischemic heart disease. Researchers from the Department of Cardiology at the University Medical Center Mainz have found that noise exposure...
Read Full NewsNew findings from the EMBARK study highlight Elevidys' significant long-term benefits in slowing Duchenne muscular dystrophy progression in young patients.
A study of 614 brain donors revealed that individuals with stage III or IV CTE face the greatest risk of dementia.
FDA Approves First Dual-Agent Eye Drop for Near Vision Loss
1.
Is a $2,000 Whole-Body MRI Worth It?
2.
Prostate cancer explained: From antigen tests to treatment options
3.
Sydney researchers identify new tools to improve cancer diagnosis and treatment.
4.
Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says
5.
Universal screening approach achieves a comparable detection rate of lung cancer
1.
Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
4.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
5.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge